The LOX inhibitor β-aminopropionitrile (BAPN) suppresses LOX enzymatic activity, blocks collagen crosslinking, reverses tumor ECM stiffness, and reduces collagen fiber thickness, linearization, and density. Here, LOX is linked to neoplasm.